Pharmaceutical pricing authority discussed issue in 2019, show documents The shortage of key leprosy drug clofazimine in the country is not of recent origin, but a long-standing problem not properly addressed by the Union government, official documents show. Minutes of a meeting of the National Pharmaceutical Pricing Authority (NPPA) under the Drug Pricing Control Order […]
Presence in additional than 42 countries, we have a core goal to increase access to affordable high-quality medicines around the world Lyophilized Vials – With 2 technology Freeze Dryers/ Lyophilizers our annual production capability is four million vials (10 mL). Taj Pharmaceuticals is leading sterile manufacturing, excellent Lyophilized Injections technology and numerous delivery systems with 21 CFR 11 […]
Ivermectin led to a 100% reduction in hospitalisation rate, a 92% reduction in mortality rate and an 86% reduction in the risk of dying from a COVID-19 infection BY WILL JONES 3 SEPTEMBER 2022 5:55 PM Regular use of ivermectin led to a 100% reduction in hospitalisation rate, a 92% reduction in mortality rate and […]
Each day is a brand-new opportunity for Taj Pharma Taj Pharmaceuticals has established itself as a top generic pharmaceutical company. With a product range that exceeds 4600 compositions across all therapeutic areas, it has successfully won the heart of consumers across the globe. The company is acclaimed as one of the top 10 pharmaceutical firms […]
Potassium iodide is a salt of stable iodine, which is needed by the human body to produce thyroid hormones. Most of the iodine that people have in their bodies comes from the food they eat. However, radioactive iodine can be released into the air after a nuclear event, and inhaled into the lungs and then […]
Pharmaceutical firm Taj Pharma has announced that it has introduced Covid-19 treatment drug Molnupiravir under brand name “Molnutaj” in India. Molnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, drug maker said.
Meta-analysis finds some ivermectin benefits in COVID-19 patient An analysis published in Open Forum Infectious Diseases found a 56% reduced risk of mortality for COVID-19 patients taking the anti-parasitic drug ivermectin compared to standard of care or another therapy. The study pulled data from 24 randomized trials involving 3,328 patients with moderate to severe COVID-19. […]
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM […]
A new peer-reviewed study by Dr Pierre Kory and colleagues on Ivermectin has been published in the American Journal of Therapeutics. Entitled “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19“, it provides a new authoritative overview of the evidence to date and calls for the widely […]
‘A combination of approved Ivermectin, Zinc and Doxycycline has shown positive results for COVID-19 and should be considered immediately to fight the pandemic’ Australia’s The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, DSc, FRACP,FACP,FACG, AGAF, says FDA and TGA approved Ivermectin which he uses regularly in his […]